| Names | |
|---|---|
| Preferred IUPAC name | 4-Fluorobutanoic acid |
| Other names | 2-Oxo-4-fluorobutyric acid 4-Fluoro-2-oxobutanoic acid 2-Keto-4-fluorobutyric acid |
| Pronunciation | /ˌpiːˈflʊə.roʊ.ɪl.bjuːˈtɪr.ɪk ˈæs.ɪd/ |
| Identifiers | |
| CAS Number | 371-31-9 |
| 3D model (JSmol) | `3D Model (JSmol) String for P-Fluoroylbutyric Acid:` `CC(CC(=O)O)CF` |
| Beilstein Reference | 2798737 |
| ChEBI | CHEBI:84752 |
| ChEMBL | CHEMBL44777 |
| ChemSpider | 24989929 |
| DrugBank | DB07962 |
| ECHA InfoCard | 100.035.301 |
| EC Number | 248-929-7 |
| Gmelin Reference | 1311060 |
| KEGG | C18633 |
| MeSH | D000077225 |
| PubChem CID | 14266719 |
| RTECS number | EO5950000 |
| UNII | 6WI3O52I24 |
| UN number | Not assigned |
| CompTox Dashboard (EPA) | DTXSID4016175 |
| Properties | |
| Chemical formula | C4H7FO2 |
| Molar mass | 122.11 g/mol |
| Appearance | Colorless to light yellow liquid |
| Odor | pungent |
| Density | 1.192 g/cm3 |
| Solubility in water | Soluble in water |
| log P | 0.30 |
| Vapor pressure | 0.000336 mmHg at 25°C |
| Acidity (pKa) | 3.88 |
| Basicity (pKb) | 1.98 |
| Magnetic susceptibility (χ) | -38.8e-6 cm³/mol |
| Refractive index (nD) | 1.4140 |
| Viscosity | 2.078 cP |
| Dipole moment | 2.4271 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 188.0 J/mol·K |
| Std enthalpy of formation (ΔfH⦵298) | -703.7 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -2957.4 kJ/mol |
| Pharmacology | |
| ATC code | |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes severe skin burns and eye damage. Causes serious eye damage. |
| GHS labelling | GHS02, GHS07 |
| Pictograms | GHS05,GHS07 |
| Signal word | Danger |
| Hazard statements | H302, H314 |
| Precautionary statements | P280, P301+P312, P305+P351+P338, P332+P313, P337+P313 |
| NFPA 704 (fire diamond) | 1-3-0-~ |
| Flash point | 113 °C |
| NIOSH | NA5600000 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 2 mg/m³ |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds | Butyric acid Valeric acid p-Fluorobenzoic acid 3-Fluorobutyric acid 4-Fluorobutyric acid |
| Property | Manufacturer Commentary |
|---|---|
| Product Name & IUPAC Name | In industrial production, P-Fluoroylbutyric Acid is referenced by its systematic IUPAC name and sometimes by its positionally descriptive names. Naming selection often aligns with regional familiarity in documentation and regulatory filings. A precise name supports traceability across process control, logistics, and regulatory submissions. |
| Chemical Formula | The chemical formula assigned to P-Fluoroylbutyric Acid is determined by structural characterization, typically confirmed by in-house analytical testing through NMR and MS during development. Accurate formula reporting underpins the labelling, material safety documentation, and compliance verification for both internal and customer-facing records. The formula assignment is consistent across product grades. |
| Synonyms & Trade Names | Synonym usage reflects market practices, regulatory context, and customer specification lists. Trade names may exist in proprietary supply chains. The technical function and performance grade dictate synonym clarity for raw material acceptance and downstream application validation. |
| HS Code & Customs Classification | HS Code assignment relies on the base chemical structure and harmonization rules. Customs codes for P-Fluoroylbutyric Acid derive from international and domestic classification principles, often cross-checked for consistency with similar fluoroalkyl acids. Entry documentation references the code directly from chemoinformatics records and follows updates in tariff adjustments or regulatory notifications. The selected HS code will influence import duty, documentation review, and reporting obligations. For process shipments, precise customs classification helps avoid rejections, delays, and compliance bottlenecks. |
Consistency in product identity demands routine batch confirmation using analytical tools calibrated for both raw material and final product matrices. Slight variance in nomenclature may affect regulatory filing, so harmonization of naming—both locally and for export—is scrutinized in QA review. Formulation of product technical sheets is based on the identity established during R&D and pilot scale-up, with adjustments as end-use industries adopt new standards or regional laws evolve.
Purity standards, synonym application, and even customs code specificity often differ by industry and customer. Pharmaceutical or fine chemicals sectors may require extended synonym records due to regulatory tracebacks and multi-jurisdiction compliance. For each grade, a review of chemical identity documentation is built into the batch record release process to minimize misclassification risks during transport and customs clearance.
Careful recording of formula and customs code in batch documentation is critical. Any misstatement can disrupt downstream processing, generate delays at borders, and complicate supply chain tracking. Each lot includes a traceable paper trail for identity, supporting both internal audits and third-party regulatory reviews. Production and quality teams revise documentation practices, particularly when raw materials change or when new export markets require harmonized naming and customs declarations.
Process route selection considers the desired purity, yield, and cost. Correct identification at all processing stages underpins batch integrity, especially where isomeric forms or close analogs might be present as by-products. Confirmation by orthogonal techniques (such as NMR, IR, MS) is standard, especially before shipment or formal COA release. Sourcing of raw fluorinated intermediates factors into both safety and regulatory pre-clearance, especially for export-regulated substances.
Internal release criteria for P-Fluoroylbutyric Acid enforce agreement between production records, analytical certification, and customs classification. Regular reviews of global harmonized system changes and HS code revisions are embedded into the documentation protocol to prevent compliance slip-ups. For region-specific sales, regulatory affairs validate the chemical ID against local customs lists, updating batch records as required by new rules.
Industrial batches of P-Fluoroylbutyric Acid generally appear as a colorless to pale yellow liquid. This appearance remains sensitive to purity and storage conditions. Trace oxidation during transit or prolonged air exposure may introduce color shifts. The odor presents as pungent and sharp, typical of low-molecular-weight carboxylic acids, sometimes accentuated by halogen content. Melting and boiling points depend on both purity and residual solvent content; actual values should be verified against the specific batch release record.
Measured density can fluctuate with temperature and trace impurity levels. In industrial tanks, stratification is minimal when material is freshly distilled. Container selection for storage is often based on observed corrosivity and handling temperature.
Under sealed conditions and reduced light, this acid exhibits long-term chemical stability. Discoloration or hydrolysis increases in the presence of strong bases or prolonged contact with moisture. Avoiding steel and non-fluoropolymer plastics during high-purity processing minimizes decomposition or side-product formation.
Solubility in polar solvents, including water, alcohols, and acetone, aligns with expectations for low-carbon chain fluoroacids; actual solubility metrics vary by grade and phase temperature. For neutralization or dilution, acid addition to solvent is preferred to prevent localized exotherm or precipitation. pH adjustment protocols depend on downstream requirements, especially in pharma or fine chemicals contexts.
Specification requirements for P-Fluoroylbutyric Acid depend on target market: technical grade for bulk intermediates, higher-purity variants for pharmaceutical or agrochemical use. Typical release specifications focus on acidity, color, heavies, fluorine content, and trace halide levels, but precise figures are set case by case.
Key impurities arise from incomplete fluorination, unsaturated side-products, and residual starting materials. Limits for these commonly reflect downstream end-use and regulatory filings. For high-purity batches, allowable content of non-fluorinated butyric acid and heavy metals may be set to ppm or below, with each lot subject to both in-process and post-filtration checks.
Industry practice relies on titration, gas chromatography, and IR spectroscopy for primary identity and assay determination. Trace impurity and residual solvent quantification adopt internal validated methods unless externally mandated by customer specification, with reference standards traceable to recognized agencies.
Raw materials selection centers on reliability of supply and consistent impurity profile. Core inputs include butyric acid derivatives and fluorinating agents. Vendors undergo pre-qualification; changes in feed quality prompt full process revalidation.
Most routes employ controlled fluorination of butyric acid or its esters, sometimes starting from substituted butyric acid with direct fluorination. Batch and continuous processes both see use, depending on order size and impurity risk. Reaction condition adjustments may be made for scale, impurity handling, and waste management.
Key process points include accurate dosing of fluorine source, tight reaction temperature ranges, moisture exclusion, and continuous by-product separation. Distillation under reduced pressure follows reaction for purification, with additional treatments based on impurity spectrum observed in crude output.
Each batch passes through in-process quality verification, intermediate checks for key impurities, and final release panels per contractual agreements. Internal standards may be refined in consultation with major customers or regulatory expectations.
This acid serves as a substrate in further functionalization—halogen exchange, amide or ester formation, or Grignard-type processes. Typical reactions leverage the reactivity of the terminal carboxyl group, with the fluorine substituent imparting desirable electronic and steric effects for target molecule synthesis.
Conditions chosen reflect both safety and yield priorities. Catalysts are unnecessary for most transformations, but selection of solvent and temperature can dictate rate and by-product levels. All parameters are grade- and route-dependent.
Principal applications include fluorinated intermediates used in agrochemicals, pharmaceuticals, and specialty polymers. Modification potential remains broad, shaped by customer application and regulatory context.
Sensitive to moisture and reactive toward basic metals. Recommended storage in fluoropolymer-lined or glass containers; stainless may be permissible if strict dryness is maintained. Lower temperatures extend product life, with avoidance of direct sunlight or heat sources reducing decomposition risk. In bulk, nitrogen blanketing used in some facilities to minimize oxidative side reactions.
Material selection for packaging should match shipment duration and environmental control at the destination. Incompatible materials, such as low-grade steel or some plastics, risk leaching or product degradation.
Shelf life depends on storage control; common signs of degradation include discoloration, odor intensity increase, and loss of assay. Internal retention samples and periodic re-analysis provide empirical basis for shelf-life assignment and customer notification.
Hazard class assignment relies on the acid’s corrosivity, volatility, and systemic toxicity. Standard GHS labeling covers skin and eye irritation, inhalation hazard, and environmental impact warnings.
Liquid and vapor pose risks to eyes, respiratory tract, and skin. Industrial users implement engineering controls—ventilation, local exhaust, PPE. Avoiding inhalation and direct contact stands as standard best practice.
Systemic toxicity data depends on purer grades and relevant exposure pathways. Internal data sheets reference published studies or, where absent, call for limited pilot handling with engineering control verification.
Workplace exposure controls take into account volatility, acid strength, and batch volume. Detailed limits align with regional regulations and occupational exposure guidance. In manufacturing, closed-system handling with regular monitoring minimizes operator risk.
From a manufacturer’s standpoint, P-Fluoroylbutyric Acid production capacity is shaped by reactor throughput, solvent recovery rates, and the reliability of process integration. Recent trends show more demand for mid to high-purity grades in custom synthesis, which can stretch equipment utilization, especially for small-batch requests. Bulk supply hinges on planning multi-purpose batch runs, where downtime for cleaning validation grows as purity specs tighten. Plant output varies: domestic and export constraints drive priority allocation to high-margin or long-term contract clients, especially where repeated qualification steps or customer audits exist.
Order lead times depend on grade, allocation pipeline, and process scheduling. Standard-grade availability improves with batch campaign scheduling, often with MOQ scaling from laboratory scale (as low as several kilograms) to drum-level quantities for industrial buyers. Custom synthesis or high-purity requirements extend lead times, especially when new validation or analytical development is needed. For regular clients, lead times may contract with rolling forecasts. Peak-demand seasons or regulatory audit intervals may double average waiting periods, particularly for newly registered specifications.
Packaging choices respond to both purity demands and logistics. Common solutions span HDPE drums for standard and technical grades, with further options for fluorinated PE or stainless containers for moisture-critical or ultra-pure applications. On-site testing of extractables or leachables determines the suitability of packaging in pharmaceutical or regulated markets. Small-scale packaging for R&D shipments typically uses sealed bottles or bags, with each packaging size validated for compatibility, seal integrity, and compliance requirements from end markets.
Shipping modes frequently default to sea freight for large volumes, but air shipment options are available for supply emergencies, subject to regulatory constraints. Solvent content or hazardous classifications can affect carrier acceptance. Payment terms for established customers usually extend to net 30 or net 60 days, but new clients often encounter advance payment or L/C conditions until supply reliability is demonstrated. Market entrants in strict regulatory jurisdictions may prompt adaptation of Incoterms and customized logistic arrangements.
Raw material costs are driven primarily by upstream fluorination agents (e.g. select fluorinated hydrocarbons, fluorinating intermediates), acid precursors, and energy inputs. Spot shortages of key reagents (such as those relying on captive fluorine or specialist organic intermediates) can sharply shift delivered cost, especially if import restrictions or environmental levies in source countries adjust upstream availability. Grade-specific costs factor strongly: high-purity runs pull higher solvent and labor requirements due to repeated purification and stringent analytical testing.
The supply chain for key intermediates, especially those influenced by energy market swings or feedstock rationing, is the primary cause of price volatility. Environmental compliance for emissions and waste from fluorination processes further impacts fixed and variable costs. Major plant turnarounds at feedstock producers or regulatory enforcement actions at upstream vendors sometimes trigger multi-quarter price shocks. Logistical blockages, port congestion, and freight rate swings add further unpredictability to delivered prices.
Grade and purity are the strongest levers behind price differences. Pharmaceutical and electronic grades demand higher analytical release testing, with batch rejection risk built into the price. Technical and industrial specifications relax some impurity thresholds, allowing streamlined processes and larger lot runs. Packaging certification—especially for export into Europe or the US—adds another layer of cost for traceability, shelf life validation, and UN-approved documentation. Clients requiring bespoke blend ratios, traceable certification, or cross-contamination studies should expect incremental price segments.
Demand remains concentrated in specialty chemical, agrochemical, and pharmaceutical intermediates, with Europe, US, and East Asia showing the highest customer density. Downstream growth in contract manufacturing and innovation-driven segments supports slight long-term demand growth, but short-term fluctuations persist, especially with inventory cycles and end-market regulatory reviews. Supply at the manufacturer level often faces spot constraints tied to multi-plant capacity swings and complex raw material streams.
US and Europe maintain robust regulatory and performance demands, increasing material traceability and documentation overhead. Japan’s procurement emphasizes certification and long-term reliability, adding resource commitment to customer-specific lots. India has increased local production but remains dependent on imported intermediates, impacting local pricing volatility. China’s position as a key producer supports baseline price stabilization but is vulnerable to sudden policy changes involving energy or environmental controls.
Current data indicates continued sensitivity to raw material and energy markets, with steady to moderate upward price bias through 2026. Global decarbonization targets and emissions regulations may increase process costs, especially for high-purity or pharmaceutical applications, lending upward pressure to contract prices. Regional supply diversification could limit volatility, but new regulatory hurdles in China, the EU, or the US may create short-term supply squeezes. Buyers with strategic partnerships or JV access to upstream intermediates are better positioned to manage 2026 contract exposure.
Price analysis derives from actual order histories, customer negotiation outcomes, and year-on-year procurement campaign reports, cross-referenced with public regulatory filings and chemical trade statistics. Methodology weights purchasing manager feedback and spot market evaluations against historical production and compliance event timelines.
Production realignment at several Asian plants has adjusted the timing and batch sizes supplied to both domestic and export clients. Moves in port fee structures and regional power shortages have raised logistics and energy surcharges, which float into delivered product pricing. Customer R&D requests for higher-spec grades in life sciences and electronics segments have grown, intensifying resource allocation to small-lot runs.
Compliance with REACH, TSCA, and Chinese regulatory systems has triggered additional product registration, safety data compilation, and process validation requirements. Enforcement of stricter wastewater and workplace exposure standards has increased purification investment, particularly affecting cost structure for high-specification lots. Adjustments to European CLP classification, as well as new import tariffs in select US states, further modify market access and compliance protocols.
Manufacturing teams have dedicated more QA resources to customer-specific analytical method transfers and validation exercises. Investments in supply chain diversification and renewable energy sourcing support cost resilience even as upstream volatility persists. Internal standard operating procedures undergo regular updates to adapt to shifting regulatory landscapes, while regular audits and customer visits anchor traceability and batch record compliance, especially for regulated endpoint markets.
P-Fluoroylbutyric Acid finds application in agrochemical synthesis, pharmaceutical intermediates, materials research, and specialty fine chemicals manufacturing. Production teams often see the strongest demand from process developers focusing on fluorinated intermediates for targeted molecule construction. Routine inquiries come from organizations optimizing synthetic routes for custom APIs and advanced organic compounds. Some R&D buyers require small volumes for discovery projects, while downstream formulators specify bulk grades for commercial-scale processes.
| Industry | Typical Grade(s) | Primary Quality Focus |
|---|---|---|
| Pharmaceutical Synthesis | Pharma/GMP, High Purity | Trace impurity profile, residual solvents, batch reproducibility |
| Agrochemical Intermediates | Technical Grade, Industrial Grade | Total purity, metal content, cost-performance, process compatibility |
| Materials Science & Fine Chemicals | Standard, Custom Purified | Key impurity identification, application-driven purity adjustments |
Technical and production teams consider the following points when mapping application to grade:
A clear definition of the end-use and downstream process is essential for narrowing grade options. Internal product management systems require that project managers specify the application (e.g., pharmaceutical synthesis, research, crop protection) before grade recommendations.
Compliance with pharmacopoeia standards, REACH registration, or regional environmental regulations directly impacts grade selection. Regulatory compliance checks guide the need for detailed impurity data, batch traceability, or full GMP documentation sets. Teams in regulated industries must validate documentation sufficiency and control points in the manufacturing chain.
Purity affects process yield, catalyst compatibility, and downstream safety. Grade selection involves reviewing analytical data for residual solvents, precursors, related organic impurities, and trace elements. Custom purification levels can be discussed in cases where downstream processes show sensitivity to specific impurities identified by customers or application engineers.
Production and logistics departments report that small-volume, high-purity batches incur higher quality control expenses, especially under GMP or custom-prepared protocols. Large-scale clients often favor technical or standard grades for cost competitiveness, except in cases where application risk factors override price considerations.
Manufacturing policy mandates that customers validate performance with sample lots prior to large-scale purchase. In practical terms, the technical service team reviews in-process analysis, batch history, and downstream compatibility results before releasing production volumes for customer validation at pilot or commercial scale.
Source purity of precursors and fluorinating agents directly impacts the achievable end-product grade. Technical staff track batch origins, contamination risk, and supply lot consistency as part of supplier qualification. Supply interruptions can influence the choice between synthesis routes or intermediate sources.
Route selection aims at minimizing byproduct formation and maximizing process yield based on grade targets. Staff select between direct fluorination and stepwise modification, depending on raw material cost, process safety, and required analytical outcome. Batch data highlight yield-efficiency tradeoffs between alternative methods.
Most process deviations and impurity formation arise from temperature fluctuations, incomplete conversion, reagent control, or equipment cleaning errors. Analytical support tracks trends in off-spec impurities to identify process drift at an early stage. Release criteria and in-process control procedures adapt based on recent impurity profiles and customer complaint data.
Purification steps are tailored to the target grade. GMP and pharma projects add multi-stage purification and more frequent in-process monitoring of critical parameters including residual fluoride, color, organic byproducts, and water content. Elevation in impurity concentrations triggers corrective actions by the quality team with updates to process logs and standard operating procedures.
Consistency across campaigns depends on robust batch documentation, periodic calibration of analytical instrumentation, and feedback from end-use evaluations. Internal review of previous production campaigns provides the baseline for setting acceptance windows for each grade. Out-of-family batch data prompt investigations and process adjustments to realign with the internal quality system or client-specific requirements.
Release criteria derive from the intersection of internal specifications, customer requirements, and application risk assessments. Analytical release focuses on content, impurity maxima, residual solvent load, and physical appearance. Custom grades are always finalized in conjunction with the client’s specification sheet and downstream test results.
Production of P-Fluoroylbutyric Acid follows compliant quality management systems. Plant-level certifications, such as ISO 9001, underpin in-house protocols. Certification audits cover raw material vetting, process validation, and documentation traceability through all critical steps. Operators log batch records for each lot, tracing raw fluorinated inputs to final drum or bulk transfer.
P-Fluoroylbutyric Acid grades may comply with sector-specific requirements, especially when destined for regulated applications such as custom intermediates or electronics. If export or local compliance marks are essential, these are discussed at the order inquiry stage, as guidelines and test standards (e.g., purity, trace impurity content) depend heavily on downstream use and jurisdiction. Documentation for specific grade compliance—such as food contact or pharmaceutical intermediate status—relies on the customer’s intended process and downstream regulatory framework.
Every lot includes a full Certificate of Analysis (CoA) based on final quality control release. The CoA details tested parameters, testing methods, and result ranges for specific batch numbers. Batch sample records, process control charts, and impurity profile summaries can be provided for qualified purchasing partners under mutual confidentiality understanding. Regulatory documentation (such as REACH registration status or export license information) is provided as required for each shipment route or destination. Auditable retention of data and approval procedures allow for retrospective traceability if any issues occur downstream.
Core synthesis routes for P-Fluoroylbutyric Acid have been optimized to address both productivity and raw material supply volatility. Main production lines run with buffer capacity, accommodating changes in projected monthly volumes, especially in custom or campaign-mode production cycles. Partnership models account for periodic demand fluctuations, annual contract volumes, and spot request spikes. Collaboration terms—such as take-or-pay arrangements, rolling forecasts, and inventory holding—are outlined to match supply assurance with customer process planning.
Industry practice reinforces selection of backbone raw materials and continuous process steps to reduce reliance on single-source critical chemicals. Key process control points include real-time monitoring of fluorination efficiency, byproduct management, and batch-to-batch variance tracking. Strategic planning matches plant output with contractually committed supply, with regular debottlenecking reviews. Buffer stock and staggered production runs help offset market or logistics disruptions.
Sample dispatch involves quality-reviewed material from representative production runs. Material selection accounts for grade and application discussion during inquiry. Shipping follows regulatory protocols for fluorinated intermediates, including documentation of prior testing. Customers requesting samples participate in specification confirmation for their intended process, including joint review of application fit and interface with in-house R&D or pilot scale teams if needed.
Flexible cooperation arrangements derive from both technical and commercial integration with customer operations. These include contracted volume vs. spot buys, scheduling tailored to production outages or end-use qualification phases, and mutually agreed sharing of inventory or logistics cost in the event of unexpected shipment issues. For process development or scale-up, split deliveries and milestone-driven stage shipments can be integrated into the supply agreement. Ongoing communication between technical, quality, and commercial teams ensures alignment between real-world manufacturing schedules and actual ordering patterns.
In the industrial synthesis arena, P-Fluoroylbutyric Acid has become a focus due to its application potential in pharmaceutical intermediates and custom synthesis. Current R&D centers on route optimization to reduce impurity profiles, particularly for downstream requirements in active pharmaceutical ingredient (API) synthesis. Shift away from corrosive fluorination reagents is evident, with greater scrutiny over byproduct management and batch-to-batch consistency.
Recent technical literature and pilot projects highlight the use of P-Fluoroylbutyric Acid in developing fluorinated building blocks for agrochemicals and advanced materials. This shift demands process redesign to achieve higher purity and tailored functionalization, as trace fluorinated impurities can impact biological assay outcomes and compound registration.
Production-scale synthesis presents recurring difficulty in controlling regioselectivity, especially in multi-step sequences involving fluorination. Side reactions generate related fluorinated compounds, challenging downstream purification. Continuous processing and in-line analytical monitoring have been adopted at the pilot scale to mitigate these effects, supporting a move toward shorter cycle times and greater operator safety by minimizing manual intervention with hazardous reagents.
Production capacity forecasts anticipate moderate growth as more pharmaceutical and specialty chemical manufacturers qualify P-Fluoroylbutyric Acid for fluorine-integration projects. Customer demand correlates strongly with regulatory approvals and the success rate of fluorinated compound portfolios in clinical and pre-clinical studies. Availability of process-grade material closely follows new product launches from the pharmaceutical sector.
The next generation of process routes relies on milder fluorination options and continuous-flow technologies that reduce raw material input variance and lower overall waste. In response to both regulatory drivers and market needs, process control upgrades focus on real-time impurity tracking, resulting in fewer off-spec batches and more robust release criteria. Early adopters implement digital tracking of batch genealogy and chain-of-custody documentation for both audit purposes and customer transparency.
Process developments emphasize solvent reduction and recovery, with specific assessment of fluorinated waste streams and closed-loop operations where technically feasible. Transition metals and persistent mineral fluorides in effluent streams remain a key challenge, requiring investment in custom on-site remediation or contract waste management solutions. Green chemistry initiatives aim to substitute high-toxicity reagents with less hazardous alternatives, assessing technical tradeoffs in product yield and consistency.
Application engineers and technical managers provide direct consultation on grade selection, with recommendations based on customer-specific downstream integration requirements, impurity sensitivity, and regulatory status. Guidance on formulation, solvent compatibility, and downstream synthetic steps supports customer process transfer and scale-up activities.
Collaboration during pilot trials or scale-up addresses questions on impurity carryover, process debottlenecking, and waste minimization strategies. Technical support includes batch sample analysis and feedback on in-process control, enabling real-time adjustment of operational parameters in the customer's facility. Where end-use applications require, the technical team can support data package preparation for regulatory submission or validation.
Quality assurance and logistics teams commit to prompt non-conformance investigations and root cause analysis in the event of customer-reported quality or handling issues. Batch-specific documentation and change notification systems underpin product release, enabling traceability should any deviation from internal control criteria or customer requirements occur. Ongoing batch-to-batch monitoring supports both the manufacturer’s internal continuous improvement and end-user confidence in long-term supply reliability.
In our production facility, we manufacture P-Fluoroylbutyric Acid with a focus on high-output consistency. The entire process—from sourcing raw fluorinated compounds to finishing each batch—operates under one site with direct oversight from our process engineers. Our teams handle every key step, including purification, final QC, and batching, which means that specifications are tightly controlled at each stage. This integrated approach limits deviations batch-to-batch and supports stable supply for industrial schedules.
Demand for P-Fluoroylbutyric Acid largely comes from pharmaceutical intermediates and fine chemical synthesis sectors, where this molecule plays a role in introducing fluorinated functionality for next-step synthesis. Not every acid structure brings the balance of reactivity and selectivity; our material consistently serves labs and scale-up teams looking to modify biological or polymer backbones. Other outlets include agrochemical R&D and advanced material developers who require this fluorinated building block for targeted synthesis projects.
All processing is handled in-house. From raw material acceptance to final packaging, QA labs run instrument-based verifications every batch. Chromatographic purity, moisture levels, and impurity profiles are monitored using validated methods. Records follow each lot from reactor to warehouse, and all production records are maintained for traceability. This system eliminates surprises for buyers who rely on predictable assay and impurity performance in their supply chain.
We deliver P-Fluoroylbutyric Acid in tightly sealed drums and HDPE containers, supported with batch labels and COAs tied to each shipment. Built-in storage systems hold both small and bulk volumes ready for same-day deployment. This approach fits both R&D-scale users and companies running full commercial synthesis, reducing lead times and minimizing inventory risk for our partners.
Technical support teams field questions from process engineers and R&D chemists daily, covering compatibility, solubility, and handling strategies under real manufacturing conditions. Teams also advise on storage conditions and transfer systems based on the acid’s physical and chemical characteristics. This feedback loop between plant floor and technical support speeds resolution for any process upsets or adaptation to new synthetic routes.
Direct control over every production variable enables reliability in both product and timelines. Manufacturing companies value the assurance that comes with single-source production—less time chasing deviations, fewer delays due to intermediate shortages, and transparency in company-to-company business. Procurement departments can align purchasing with production forecasts, monitor real-time supply availability, and ensure that compliance documentation aligns with global regulatory requirements. Distributors and integrators benefit from direct shipments, reducing the steps between source and end application.
Our production of P-Fluoroylbutyric Acid supports industries pushing for improvements in synthesis and performance chemistry. By holding all production, quality, and packaging in-house, we offer consistent supply and technical assurance for companies seeking reliable sourcing of fine chemical intermediates at scale.
P-Fluoroylbutyric acid draws increasing attention in custom synthesis and advanced intermediate applications. As a direct manufacturer, we focus on purity and analytical transparency to support demanding research and production requirements. P-Fluoroylbutyric acid is not a standard catalog item in most global markets, so maintaining precise quality control becomes both a technical and a competitive imperative.
Consistent lot-to-lot chemical purity underpins meaningful performance in downstream applications. Our typical specification for the pure form of p-fluoroylbutyric acid targets a minimum assay of 99.0% by HPLC. Impurities, such as related fluorinated acids, residual solvents, and moisture, receive close control through validated batch records. Residual solvent content commonly aligns with ICH Q3C guidelines, though our technical team will customize limits for unique client processes or regional regulatory constraints. Water content is tracked below 0.5% by Karl Fischer titration unless otherwise required. Chromatographic purity ensures that the presence of regioisomers and high-volatility fragments never compromises reaction fidelity for specialty syntheses.
The backbone of routine quality assessment for this compound is reverse phase HPLC for content and impurities. We calibrate against properly characterized reference standards to quantify major and minor peaks. The fluorinated carboxylic acid group responds well to UV detection with common wavelengths set between 210-230 nm, based on absorption spectra. LC-MS serves regularly in the confirmatory stage to flag isobaric contaminants or detect trace unknowns that fall under general impurity screens. When projects enter more regulated environments, we validate HPLC methods to industry standards and supply compound-specific validation summaries to clients who request them.
Infrared spectroscopy (FTIR) and nuclear magnetic resonance (NMR) methods round out standard batch release testing. Each lot sees documented FTIR comparison for functional group identity, focusing especially on the carbonyl and aromatic fluoride stretches. NMR analysis, both 1H and 19F, further confirms structure assignment, checks for positional isomers, and delivers quantitative results when necessary. We monitor trace metals by ICP-MS, especially for pharmaceutical or electronic R&D partners with strict contamination tolerances.
One challenge arises from the strongly polar carboxylic acid head group, which increases the risk of metal ion contamination during synthesis in standard reactors. To minimize this, our process engineering includes lined vessels and ultra-pure reagents for every production run. Where requested, we document full traceability for starting materials and processing aids. Solvent selection during synthesis and purification is optimized to minimize formation of persistent volatile residues.
Quality in p-fluoroylbutyric acid depends as much on manufacturing consistency as on robust analytics. Our technical team refines each analytical method as standards and downstream regulations advance. We consult routinely with end users to adapt purity specifications for their process realities. Analysts regularly train on emerging impurity profiling tools, so new peaks are addressed swiftly in any production revision.
Every batch ships with a detailed certificate of analysis listing all major measured parameters. For demanding R&D or scale-up programs, we can provide full characterization dossiers, customized impurity breakdowns, and additional chromatographic profiles. This keeps development cycles moving at the speed our partners require, with risk management always grounded in direct, transparent manufacturing data.
Access to specialty chemicals like P-Fluoroylbutyric Acid shapes both research progress and industrial application. From our own production facility, we see clear trends in demand for both pilot-scale studies and commercial synthesis. Often, formulation development or downstream processing relies on substances produced strictly to consistent, high standards, and this requires a tightly controlled industrial environment—from raw material sourcing to the delivery of finished goods.
We manufacture P-Fluoroylbutyric Acid on dedicated lines designed for halogenated carboxylic acids. The process involves strict temperature and moisture control, as even small deviations during fluorination and subsequent acidification phases can impact assay and purity. We scale production in batch reactors equipped with corrosion-resistant linings, which allows us to switch quickly between R&D scale (typically several kilograms) and full drum volumes.
Based on real-world production loads, we keep regular stock of P-Fluoroylbutyric Acid in sizes suitable for both laboratory evaluation and commercial projects. Our standard packaging comes in sealed HDPE containers for lots weighing from 1 kilogram up to 25 kilograms per drum. For projects requiring hundreds of kilograms, we produce on a campaign basis, with validated cleaning procedures between production cycles to prevent cross-contamination.
Setting a clear minimum order quantity has helped both our own logistics and our clients’ planning. For P-Fluoroylbutyric Acid, our minimum batch release stands at 1 kilogram. This threshold balances packaging costs, material shelf stability, and compliance with storage guidelines. Too small a batch drives up per-unit costs and complicates process scheduling—issues every producer of specialized intermediates knows well. Conversely, one kilogram supports most customers needing to qualify a new intermediate before committing to higher-volume runs.
Production monitoring extends beyond the reactor floor. Every bulk lot ships with its own certificate of analysis based on validated analytical methods—typically, ^1H and ^19F NMR, GC, and moisture content. Our site’s quality control laboratory checks every lot before release. Supply chains for fluorinated organics can become less stable at scale, so we track precursor procurement, process yield, and finished product consistency down to individual production dates and lot numbers.
Maintaining flexibility in batch sizing supports a wide range of clients, from pharmaceutical researchers evaluating new molecular scaffolds, to polymer scientists scaling new designs. Running a robust manufacturing schedule keeps supply both predictable and competitive, with emergency production windows built into our planners for urgent or seasonal orders.
We support OEM customers, contract manufacturers, and multinational research departments, removing the uncertainty that so often plagues specialty chemical sourcing through indirect channels. Warehousing at the point of manufacture shortens lead times and lets us maintain batch integrity up to the moment of shipment. Our technical team reviews every inquiry and ensures specifications fit the required end-use—no handoffs, no third-party complications.
Bulk supply of P-Fluoroylbutyric Acid reflects not just production capacity, but years of refining processes for reliability and safety. We recognize the challenges in sourcing high-purity intermediates, and our team’s responsiveness is shaped by what we’ve learned running onsite operations, not by what’s possible on generic reseller listings. For precise data about weekly or monthly production ceilings, we can provide detailed production schedules upon request.
As a direct producer of P-Fluoroylbutyric Acid, we manage everything from raw material sourcing through final packaging on-site. This means oversight for every drum, pail, or container leaving our facility. Handling the logistics of shipping organic acids—especially those with halogenated functional groups—demands understanding both the chemistry and the regulatory framework. In our experience, P-Fluoroylbutyric Acid consistently draws attention from not only customs but also carrier safety departments due to its chemical structure and associated risks.
P-Fluoroylbutyric Acid falls under regulations for hazardous materials in most jurisdictions. Its molecular design includes a fluorine atom attached to a carboxylic backbone, which not only increases reactivity but also triggers a need for careful hazard assessment. We do not move a single shipment without verifying its correct classification under the UN Recommendations on the Transport of Dangerous Goods, along with ADR (Europe), DOT (United States), IATA (air cargo), and IMDG (maritime) guidelines. Our compliance measures stand up to regular inspection, which means every outgoing package travels with a verified Safety Data Sheet along with completed shipping paperwork, including the proper hazard labels and a 24-hour emergency contact.
The documentation does not stop at the bill of lading. We include a Material Safety Data Sheet (SDS) tailored to P-Fluoroylbutyric Acid, outlining hazards, storage precautions, and immediate response actions. These documents are required not only by law but by any logistics provider transporting this material over borders or between states. Customs officials scrutinize these carefully, and any missing or unclear document can delay a shipment by days or weeks. Each consignment carries the correct UN number indicated for hazardous organic acids. Carriers and handlers both in our facility and externally receive clear instructions as part of the dispatch protocol.
Special attention goes into choosing the right container and secondary packaging. Our production team always selects chemical-resistant materials for lining and caps, checked for compatibility with P-Fluoroylbutyric Acid based on real-world exposure data. Finished containers carry the proper hazard pictograms (such as corrosive or harmful, determined by the acid’s properties), with labels affixed before leaving our warehouse. We do not rely on guesswork for marking; labeling remains consistent with GHS standards and is double-checked by quality control staff prior to shipment.
Staff involved in the filling, documentation, and dispatch of P-Fluoroylbutyric Acid receive regular training on hazardous goods handling procedures. In our factory, no shipment moves unless those processing the consignment can demonstrate knowledge of both local and international regulations. Periodic audits catch errors before they reach an external carrier. Over years of manufacturing and transporting specialty organic acids, this approach created a track record of safe and compliant deliveries.
Every regulatory update is reviewed by our compliance team. We maintain direct relationships with industry bodies and regularly update our SDS data to reflect any new hazard information. Customers can expect from us not only consistent product quality but the paperwork and hazard controls trusted by end-users, procurement teams, and legal departments throughout the supply chain.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales9@bouling-chem.com, +8615651039172 or WhatsApp: +8615651039172